Cigarette smoking and pulmonary diffusion defects in rheumatoid arthritis.
The pathogenesis of lung disease in rheumatoid arthritis (RA) has still to be defined. Risk factors associated with lung involvement in RA were investigated by means of pulmonary function studies in 40 RA patients without apparent lung disease. A decreased carbon monoxide (CO) diffusion capacity indicative of interstitial lung disease (ILD) was the main pulmonary function defect found in the first 20 patients. The occurrence was associated with current cigarette smoking. This association was confirmed in a case control study performed subsequently. These data suggest that ILD in RA is stimulated by smoking and provide an additional argument that modification of smoking behaviour in RA patients might lead to less severe complications.
Westedt
M L
ML
Department of Rheumatology, Leiden University Medical Center, The Netherlands.
Hazes
J M
JM
Breedveld
F C
FC
Sterk
P J
PJ
Dijkman
J H
JH
D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000378:metabolism / Q000503:physiopathology; D002245:Carbon Dioxide / Q000378:metabolism; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011653:Pulmonary Diffusing Capacity; D012907:Smoking / Q000009:adverse effects*; D014109:Total Lung Capacity
D002245:Carbon Dioxide